Psychiatry and Neurology, Neurology · New York, NY
NPI
1164463808
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5 E 98th St, Box 1138
New York, NY, 10029
Phone (212) 241-6854
Groups this clinician bills Medicare through
Medicare paid, 2024
$149K
1,842 services
Medicare patients, 2024
503
Average age 73
Drug cost, 2024
$4.5M
2,250 prescriptions
Company payments, 2025
$3,481
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Teresa M Deangelis was code 99214 (office e&m - established), 756 times for 407 patients. In total Teresa M Deangelis billed 1,842 services in 24 codes, and Medicare paid $149K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 756 | 407 | $107.60 | $81K |
| 99497 Care Management/Coordination | Office | 417 | 417 | $67.93 | $28K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 152 | 121 | $15.06 | $2,289 |
| 96138 Behavioral Health Services | Office | 65 | 61 | $33.13 | $2,153 |
| 96139 Behavioral Health Services | Office | 62 | 58 | $34.39 | $2,132 |
| 99215 Office E&M - Established | Office | 56 | 53 | $143.22 | $8,020 |
| 99205 Office E&M - New | Office | 53 | 53 | $190.91 | $10K |
| 96132 Behavioral Health Services | Office | 37 | 35 | $114.05 | $4,220 |
| 99204 Office E&M - New | Office | 33 | 33 | $149.57 | $4,936 |
| 99232 Hospital E&M - Subsequent | Facility | 25 | 20 | $71.35 | $1,784 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $120.55 | $1,929 |
By year: 2022 $120K for 1,271 services; 2023 $137K for 1,790 services; 2024 $149K for 1,842 services.
Medicare prescription drug claims, 2024
In 2024, the drug Teresa M Deangelis prescribed most often to Medicare patients was Gabapentin, with 337 prescriptions and refills. In total Teresa M Deangelis wrote 2,250 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 337 | 674 | 85 | $5,842 |
| Donepezil Hcl Generic | 152 | 316 | 40 | $1,809 |
| Baclofen Generic | 115 | 241 | 31 | $3,350 |
| Dimethyl Fumarate Generic | 111 | 131 | 14 | $204K |
| Memantine Hcl Generic | 98 | 171 | 21 | $1,946 |
| Copaxone Glatiramer Acetate | 93 | 120 | Under 11 | $707K |
| Dalfampridine Er Dalfampridine | 72 | 110 | 12 | $92K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 66 | 118 | 13 | $1,061 |
| Duloxetine Hcl Generic | 65 | 139 | 14 | $1,517 |
| Tizanidine Hcl Generic | 59 | 115 | 16 | $1,006 |
| Glatiramer Acetate Generic | 54 | 74 | Under 11 | $198K |
| Nurtec Odt Rimegepant Sulfate | 45 | 45 | Under 11 | $63K |
| Alprazolam Generic | 44 | 44 | Under 11 | $379 |
| Modafinil Generic | 42 | 58 | Under 11 | $2,091 |
| Pregabalin Generic | 37 | 55 | Under 11 | $1,479 |
Brand drugs: 400 claims; generic drugs: 1,850 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Teresa M Deangelis $3,481 ($3,481 in general payments such as food, travel and fees) from 28 companies. The largest payer was Novartis Pharmaceuticals Corporation with $683.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 60 | $683 |
| Biogen, Inc. BIIB | 23 | $372 |
| TG Therapeutics, Inc. TGTX | 8 | $350 |
| Amgen Inc. AMGN | 16 | $331 |
| Abbvie Inc. ABBV | 23 | $328 |
| Argenx US, Inc. ARGX | 11 | $298 |
| EMD Serono, Inc. MRK.DE | 4 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $98.07 |
| Genzyme Corporation SNY | 3 | $98.05 |
| Pfizer Inc. PFE | 5 | $95.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.